But I believe CYP doesn't require 3D manufacturing like bone marrow derived technologies, because of the IPSC starting material, which is uniform, consistent and infinitely expandable without facing the issues of cell senescence. I believe 3D is required for bone marrow derived cells because of the senescence issues related to batch to batch inconsistencies?
CYP surpasses the need for 3D cell scaffolding, does it not?
Please correct me if I'm wrong.
But I believe CYP doesn't require 3D manufacturing like bone...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10408 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 46000 | 1 |
View Market Depth
| Last trade - 10.29am 02/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable